Evidence map›Paper›PMID 32933043›Full record

ReviewMaterials (Basel, Switzerland)2020

Science-Based Strategies of Antiviral Coatings with Viricidal Properties for the COVID-19 Like Pandemics.

Rakesh Pemmada, Xiaoxian Zhu, Madhusmita Dash, Yubin Zhou, Seeram Ramakrishna, Xinsheng Peng, Vinoy Thomas, Sanjeev Jain, Himansu Sekhar Nanda

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rakesh PemmadaBiomedical Engineering and Technology Laboratory, Discipline of Mechanical Engineering, PDPM-Indian Institute of Information Technology Design and Manufacturing, Jabalpur 482005, MP, India.
Xiaoxian ZhuSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
Madhusmita DashSchool of Materials and Metallurgical Engineering, Indian Institute of Technology Bhubaneswar, Arugul, Odisha 752050, India.
Yubin ZhouSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
Seeram RamakrishnaCentre for Nanofibers and Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Engineering Drive 3, Singapore 117587, Singapore.ORCID 0000-0001-8479-8686
Xinsheng PengSchool of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
Vinoy ThomasDepartment of Materials Science and Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-1191-3353
Sanjeev JainBiomedical Engineering and Technology Laboratory, Discipline of Mechanical Engineering, PDPM-Indian Institute of Information Technology Design and Manufacturing, Jabalpur 482005, MP, India.
Himansu Sekhar NandaBiomedical Engineering and Technology Laboratory, Discipline of Mechanical Engineering, PDPM-Indian Institute of Information Technology Design and Manufacturing, Jabalpur 482005, MP, India.ORCID 0000-0001-5558-9885

Funding

Project 5 Nano-micro Hybrid Fibrous Materials for Containment Removal and Site RemediationP42ES027723 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LUNGU, CLAUDIU T · 2020 to 2024
$6.7M
Environmental Cadmium and COPDR01ES029981 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANTONY, VEENA B. · 2018 to 2022
$2.5M
Department of Science and Technology, Government of India SRG/2019/001504Guangdong Basic and Applied Basic Research Foundation 2019A1515111112Guangdong Medical University Scientific Research Foundation 4SG19003GaNIEHS NIH HHS P42 ES027723NIEHS NIH HHS R01 ES029981
6 · The paper itself

Abstract

The worldwide, extraordinary outbreak of coronavirus pandemic (i.e., COVID-19) and other emerging viral expansions have drawn particular interest to the design and development of novel antiviral, and viricidal, agents, with a broad-spectrum of antiviral activity. The current indispensable challenge lies in the development of universal virus repudiation systems that are reusable, and capable of inactivating pathogens, thus reducing risk of infection and transmission. In this review, science-based methods, mechanisms, and procedures, which are implemented in obtaining resultant antiviral coated substrates, used in the destruction of the strains of the different viruses, are reviewed. The constituent antiviral members are classified into a few broad groups, such as polymeric materials, metal ions/metal oxides, and functional nanomaterials, based on the type of materials used at the virus contamination sites. The action mode against enveloped viruses was depicted to vindicate the antiviral mechanism. We also disclose hypothesized strategies for development of a universal and reusable virus deactivation system against the emerging COVID-19. In the surge of the current, alarming scenario of SARS-CoV-2 infections, there is a great necessity for developing highly-innovative antiviral agents to work against the viruses. We hypothesize that some of the antiviral coatings discussed here could exert an inhibitive effect on COVID-19, indicated by the results that the coatings succeeded in obtaining against other enveloped viruses. Consequently, the coatings need to be tested and authenticated, to fabricate a wide range of coated antiviral products such as masks, gowns, surgical drapes, textiles, high-touch surfaces, and other personal protective equipment, aimed at extrication from the COVID-19 pandemic.

Indexed as

antiviralantiviral productscoatingsCOVID-19metal ions and oxidesnanomaterialspolymeric materials

Identifiers

PMID32933043
PMCPMC7558532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.